학술논문
Anti-Tumor Activity of ASTX029, a Dual Mechanism Inhibitor of ERK1/2, in Preclinical AML Models
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:7-8
Subject
Language
ISSN
0006-4971